National Institutes of Health: all 11,571 studies

Page 68 of 116. Open to participants first (945), then studies with results posted, then the rest; newest registration first within each.

• Emergency Department Initiated Tobacco Treatment (EDITT)CompletedNCT00252902Phase 1/2
• Calcium Channel Splice Variant Expression in Cardiovascular Disease and AgingCompletedNCT00251615
• Analysis of Atropine and Propranolol Induced ChangesCompletedNCT00251602Phase 1
• Anabolic Steroids and Exercise in Hemodialysis PatientsCompletedNCT00250536Not applicable
• Mathematical Modeling of the Acute Inflammatory Response Following InjuryStatus unknownNCT00250523
• Reimbursement Effects on Enrollment in Obesity TreatmentCompletedNCT00250510Not applicable
• The Immunological and Blood Effects of STA-5326 Mesylate on Patients With Crohn's DiseaseCompletedNCT00250198Phase 2
• The Role of Nitrite in Preconditioning Mediated Tolerance to Ischemic StressCompletedNCT00250185Phase 1
• PET Whole Body Biodistribution and Test Retest Bain Imaging Studies Using a Phosphodiesterase 4 Inhibitor (R)-[11C]RolipramCompletedNCT00250172Phase 1
• Contingency Management for Attendance - 2CompletedNCT00249639Not applicable
• Medication Adherence Therapy for Opioid Abusing Pain PatientsCompletedNCT00249587Phase 1/2
• Bridging Active Heroin Users to Hepatitis C Treatment Using Buprenorphine - 1CompletedNCT00249574Not applicable
• Low-Cost Contingency Management for Hispanic Outpatients - 3CompletedNCT00249548Not applicable
• Vouchers vs. Prizes for Methadone Patients - 1CompletedNCT00249522Not applicable
• Effectiveness of Nefazodone and Bupropion in Treating Marijuana Dependent IndividualsCompletedNCT00249509Phase 2
• Events Preceding Interstitial Cystitis (EPIC)CompletedNCT00248664
• Development of Limited Contact CBT Treatment for IBSCompletedNCT00248586Not applicable
• Efficacy and Safety of Bupropion for Treatment of Adolescent SmokingTerminatedNCT00248118Phase 2/3
• The Genetic Basis for Vulnerability to Substance AbuseCompletedNCT00247819
• Methylphenidate Studies for Drug Abuse Vulnerability Molecular GenenticsTerminatedNCT00247689
• Hangover, Congeners, Sleep and Occupational PerformanceCompletedNCT00247585Phase 2
• Stepped Care for Mandated College StudentsCompletedNCT00247182Phase 1
• Effect of Regular Exercise on Vascular Function and Cardiovascular Risk in a Sedentary Work ForceCompletedNCT00246883Phase 2
• PET Imaging of GABA Receptors in Succinic Semialdehyde Dehydrogenase DeficiencyCompletedNCT00246870
• Assessment of Insulin Production From Native Pancreas in Patients With Pancreas TransplantsCompletedNCT00246844
• Brain Networks Responsible for Self-AgencyCompletedNCT00246831
• Effect of Tai Chi Vs. Structured Exercise on Physical Fitness and Stress in Cancer SurvivorsCompletedNCT00246818Phase 2
• Opiate-Induced Tolerance & Hyperalgesia in Pain PatientsCompletedNCT00246532Phase 4
• Infertility Therapy for Women Age Thirty-eight and OlderStatus unknownNCT00246506Not applicable
• Vascular Aging: The Link That Bridges Age to Atherosclerosis (The VALIDATE Study)TerminatedNCT00246493
• RSV Disease in the ElderlyCompletedNCT00246480
• A Placebo-Controlled Trial of Memantine for Alcohol DependenceCompletedNCT00246415Phase 2
• Acipimox to Improve Hyperlipidemia and Insulin Sensitivity Associated With HIVCompletedNCT00246402Not applicable
• Effect of Genetics on Metabolism of EfavirenzCompletedNCT00245986Phase 4
• Possible Relation of Toll-Like Receptors and Nitric Oxide to Chronic Lung DiseaseCompletedNCT00245167
• Smokefree.Gov Website in Helping United States Federal Employees Quit SmokingCompletedNCT00245076Not applicable
• Sulindac in Preventing Breast Cancer in Women at High Risk for Breast CancerCompletedNCT00245024Phase 1
• Tipifarnib and Sorafenib Tosylate in Treating Patients With Biopsiable Advanced CancerCompletedNCT00244972Phase 1
• Convection-Enhanced Delivery of Glucocerebrosidase to Treat Type 2 Gaucher DiseaseCompletedNCT00244582
• Examining the Role of Negative Emotional States on Sedative Drug Use in Individuals With Post-Traumatic Stress DisorderCompletedNCT00244335
• Vorinostat and Gemcitabine in Treating Patients With Metastatic or Unresectable Solid TumorsCompletedNCT00243100Phase 1
• Tipifarnib and Bortezomib in Treating Patients With Relapsed Multiple MyelomaTerminatedNCT00243035Phase 1/2
• Epigenetics in the Aging ProcessCompletedNCT00242255
• Moving a Paralyzed Hand Through Use of a Brain-Computer InterfaceTerminatedNCT00242242
• Preschool Based Obesity Prevention Effectiveness TrialCompletedNCT00241878Not applicable
• Epidemiology of Depression and Heart Failure in AgingCompletedNCT00241761
• Air Pollution, Inflammation, and New Onset AsthmaCompletedNCT00241696
• H5 Booster After a Two Dose ScheduleCompletedNCT00240968Phase 2
• Revaccination With Subunit Influenza A/Vietnam/1203/2004 (H5N1) VaccineCompletedNCT00240903Phase 1
• MIRAGE: Multi-Institutional Research in Alzheimer's Genetic EpidemiologyCompletedNCT00239759
• BONSAI: Biomarkers of Nonsteroidal Anti-InflammatoriesStatus unknownNCT00239746Phase 1
• GIP: Glucose-dependent Insulinotropic PeptideCompletedNCT00239707Phase 1
• PPV: Pneumococcal Polysaccharide Vaccine in Older AdultsCompletedNCT00239694Phase 4
• Controlling Acute or Early HIV Infection With Antiretroviral Drugs, Without a Candidate Vaccine.As Reported Previously, the Candidate Vaccie Was Not Provided by the Maufacturer as PromisedCompletedNCT00238459
• Cediranib Maleate in Treating Patients With Locally Advanced or Metastatic Liver CancerCompletedNCT00238394Phase 2
• S0514 Sorafenib in Treating Patients With Unresectable or Metastatic Gallbladder Cancer or CholangiocarcinomaCompletedNCT00238212Phase 2
• Use of Midlevel Providers in Diabetes ManagementCompletedNCT00237094Not applicable
• Genetics of Interstitial CystitisCompletedNCT00237081
• Infectious Agents in Pediatric Crohn'sCompletedNCT00237055
• When to Start Anti-HIV Drugs in Children Infected With HIV (The PREDICT Study)CompletedNCT00234091Phase 3
• Defined Green Tea Catechin Extract in Preventing Esophageal Cancer in Patients With Barrett's EsophagusCompletedNCT00233935Phase 1
• Fast Food Study: Assessment of the Effects of Fast-Food on Inflammatory MarkersCompletedNCT00233311
• A Study of the Function of Hormones Present In Taste BudsCompletedNCT00233298
• Factors in Childhood Lung Susceptibility to PollutionCompletedNCT00233285
• Adherence Intervention for Minority Children With AsthmaCompletedNCT00233181Not applicable
• Inactivated Influenza Vaccine in Infants 10-22 Weeks of AgeCompletedNCT00231920Phase 1
• A Phase I Safety and Immunogenicity Study of Mix and Match of Licensed Flu Vaccine and FlumistCompletedNCT00231907Phase 1
• Triamcinolone Acetonide Injections to Treat Diabetic Macular EdemaCompletedNCT00231023Phase 2
• Molecular Genetics of Retinal DegenerationsCompletedNCT00231010
• Inactivated Influenza A/H5N1 Vaccine in the ElderlyCompletedNCT00230750Phase 1/2
• Effect of Omega-3 PUFA Supplementation in NAFLD PatientsCompletedNCT00230113Not applicable
• Iron Depletion Therapy for Type 2 DM and NAFLDCompletedNCT00230087Not applicable
• Lupus Immunosuppressive/Immunomodulatory Therapy or Stem Cell Transplant (LIST)WithdrawnNCT00230035Phase 2
• Medical Treatment of Endometriosis-Associated Pelvic PainCompletedNCT00229996Phase 3
• Idebenone to Treat Friedreich's AtaxiaCompletedNCT00229632Phase 2
• Comparing the Treatment of Alcohol Withdrawal Syndrome Using Gabapentin Versus LorazepamCompletedNCT00229125Phase 2
• Aromatase Inhibitor Clinical TrialStatus unknownNCT00228956
• Tamoxifen Pharmacogenetics and Clinical EffectsCompletedNCT00228930
• Modifying Group Therapy for Bipolar Substance Abusers - 1CompletedNCT00227838Not applicable
• The Aim of This Study is to Determine the Effectiveness of a Motivational Enhancement Intervention in Reducing Risk Behaviors (Drug and Alcohol Use, Sexual Risk Behavior, Poor Adherence to Medications) Among HIV+ Youth. - 1Status unknownNCT00227825Phase 2
• Integrated Treatment for Cocaine and Mood Disorders - 1CompletedNCT00227812Phase 2
• Vorinostat and Bortezomib in Treating Patients With Metastatic or Unresectable Solid TumorsCompletedNCT00227513Phase 1
• Nurses Helping Sudden Cardiac Arrest Survivors Recover After Getting An Implantable Cardioverter Defibrillator (ICD)CompletedNCT00226681Phase 1
• Evaluation of Brain Lesions in HIV-infected Patients for Diagnosis of Primary Central Nervous System LymphomaCompletedNCT00226304
• Early Tobacco Abstinence - 5TerminatedNCT00224965Phase 1
• Pre-ESRD Syndrome in High Risk African AmericansTerminatedNCT00224939Not applicable
• Electrical Stimulation After Total Knee ArthroplastyStatus unknownNCT00224913Phase 1
• Guideline Adherence for Heart HealthCompletedNCT00224848Phase 2
• Nebulizer Intervention for Minority Children With AsthmaCompletedNCT00218816Phase 3
• Teaching Children With Asthma and Who Live in a Rural Setting How to Self-Manage Their AsthmaCompletedNCT00218803Phase 3
• Effectiveness of Self-Help for Dually-Diagnosed Persons - 1CompletedNCT00218582Phase 1/2
• Preventing Depression in Methadone Maintenance Patients Receiving Hepatitis C Treatment - 1CompletedNCT00218556Not applicable
• Effectiveness of Naltrexone and Lofexidine in Treating Detoxified Heroin Addicts - 1CompletedNCT00218530Phase 1
• Effectiveness of Selegiline in Treating Marijuana Dependent Individuals - 1CompletedNCT00218517Phase 2
• Dextromethorphan, Gabapentin, and Oxycodone to Treat Opioid-Induced HyperalgesiaCompletedNCT00218374Not applicable
• Effects of Pre-Session Supplemental Hydromorphone on Drug Seeking Behavior in Opioid Dependent IndividualsCompletedNCT00218309
• Nicotine Lozenge to Reduce Smokeless Tobacco UseCompletedNCT00218283Phase 2
• Effectiveness of Using Tobacco Free Snuff in Reducing Negative Effects of Smokeless Tobacco UseCompletedNCT00218270Phase 2
• Using Smokeless Tobacco Products With Lower Nicotine Levels to Reduce Negative Effects of Smokeless Tobacco UseCompletedNCT00218244Phase 1/2
• Effect of Bupropion on Smoking Behavior in Smokers With SchizophreniaCompletedNCT00218231Phase 2

← National Institutes of Health overview and focus areas